Details for: CL0000838

Cell ID: CL0000838

Cell Name: lymphoid lineage restricted progenitor cell

Description: Note that this is a class of cell types, not an identified single cell type.

Synonyms: lymphoid progenitor cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for lymphoid lineage restricted progenitor cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for lymphoid lineage restricted progenitor cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for lymphoid lineage restricted progenitor cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for lymphoid lineage restricted progenitor cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  lymphoid lineage restricted progenitor cell (CL0000838)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [lymphoid lineage restricted progenitor cell](/details-cell/CL0000838) is a multipotent cell type committed to the lymphoid lineage, capable of differentiating into various lymphoid effector cells. Based on its gene significance profile in the **Overall** context, this cell's identity is prominently defined by an exceptionally high and specific expression of a suite of genes involved in RNA processing, particularly mRNA splicing and stability. This suggests that post-transcriptional gene regulation is a central and defining feature of this progenitor state. This is complemented by a signature of high metabolic activity, consistent with the bioenergetic demands required for proliferation and the execution of complex differentiation programs. ## Key Characteristics and Function Analysis of gene expression specificity (`csi_z`) highlights several core functional axes that characterize the [lymphoid lineage restricted progenitor cell](/details-cell/CL0000838). * **Intense RNA Processing and Post-Transcriptional Regulation:** The most striking feature of this cell type is the specific expression of numerous heterogeneous nuclear ribonucleoproteins (hnRNPs) and other RNA-binding proteins. Top markers include [HNRNPC](/details-gene/3183) (CSI: 26.80), [HNRNPU](/details-gene/3192) (CSI: 26.14), [HNRNPA3](/details-gene/220988) (CSI: 25.65), [HNRNPDL](/details-gene/9987) (CSI: 25.16), [HNRNPA2B1](/details-gene/3181) (CSI: 25.10), and [HNRNPA1](/details-gene/3178) (CSI: 20.38). These are joined by other critical RNA regulators such as [NCL](/details-gene/4691) (nucleolin), [PCBP2](/details-gene/5094), [RBM39](/details-gene/9584), [PABPC1](/details-gene/26986), and [YBX1](/details-gene/4904). This strong functional cluster indicates that alternative splicing, mRNA localization, and stability are fundamental mechanisms governing the cell's fate decisions and maintaining its progenitor identity. * **High Bioenergetic State:** The cell exhibits a distinct signature of high mitochondrial activity. This is evidenced by the specific expression of multiple components of the ATP synthase complex, including [ATP5MC2](/details-gene/517) (CSI: 24.77), [ATP5MG](/details-gene/10632) (CSI: 21.57), and [ATP5F1E](/details-gene/514) (CSI: 19.79), as well as subunits of the cytochrome c oxidase complex like [COX4I1](/details-gene/1327) (CSI: 21.96) and [COX7C](/details-gene/1350) (CSI: 19.52). This metabolic profile is consistent with the high energy requirements for self-renewal and differentiation characteristic of progenitor cells. * **Proliferation and Chromatin Accessibility:** The proliferative nature of this progenitor is suggested by the specific expression of [CCNI](/details-gene/10983) (Cyclin I). Furthermore, the high specificity of [NPM1](/details-gene/4869), a protein involved in ribosome biogenesis and cell cycle regulation, and [HMGB1](/details-gene/3146), a non-histone chromosomal protein that influences chromatin structure, suggests a state of active cell growth and an open chromatin landscape permissive for the transcriptional programs underlying lineage commitment. * **Lineage Identity:** The cell's identity is also defined by what it is not. The lack of specific expression for myeloid-associated genes such as [MPO](/details-gene/4353) (Myeloperoxidase) and [CSF3R](/details-gene/1441) (Granulocyte Colony-Stimulating Factor Receptor) confirms its restriction to the lymphoid lineage. Similarly, the low specificity scores for genes associated with late-stage mitosis and cell division, such as [MKI67](/details-gene/4288) and kinetochore components like [CENPU](/details-gene/79682), may indicate that while proliferative, the cell's unique identity is more defined by the preparatory and regulatory machinery than the final execution of cell division itself. ## Clinical Significance and Contextual Roles The gene signature of the [lymphoid lineage restricted progenitor cell](/details-cell/CL0000838) offers insights into its potential roles in both normal hematopoiesis and disease. The profound dependence on a specific set of RNA-binding proteins suggests that dysregulation of splicing machinery could be a critical event in the initiation of lymphoid malignancies. For instance, mutations or altered expression of genes like [HNRNPU](/details-gene/3192) or [NPM1](/details-gene/4869), a well-known factor in acute myeloid leukemia, could disrupt normal lymphoid differentiation and promote leukemogenesis. The high expression of [HMGB1](/details-gene/3146) is also clinically relevant. [HMGB1](/details-gene/3146) can act as a damage-associated molecular pattern (DAMP) when released from cells, potentially linking progenitor cell stress or death to inflammatory responses within the bone marrow microenvironment. This could influence hematopoietic output and immune surveillance. The cell's distinct bioenergetic profile may also represent a therapeutic vulnerability, as metabolic inhibitors could potentially target rapidly dividing progenitor populations in hematological cancers. ## Potential Mechanisms and Research Directions 1. **Hypothesis: The "Splicing Code" of Lymphoid Lineage Commitment.** The specific combination and high expression of numerous hnRNP family members, such as [HNRNPC](/details-gene/3183), [HNRNPU](/details-gene/3192), and [HNRNPA1](/details-gene/3178), may function as a master regulatory hub. This hub could orchestrate a specific "splicing code" that controls the alternative splicing of key transcription factors and signaling pathway components, thereby guiding the differentiation of progenitors towards T cell, B cell, or other lymphoid fates. * **Surprising Findings:** It is notable that RNA processing factors, rather than classical lineage-defining transcription factors, emerge as the most specific markers (`csi_z`). This suggests that post-transcriptional regulation is a primary and defining gatekeeping layer in early lymphoid development, preceding or acting in concert with transcriptional control. * **Testable Questions:** Does targeted depletion of [HNRNPC](/details-gene/3183) or [HNRNPU](/details-gene/3192) in lymphoid progenitors lead to a block in differentiation or a skewing towards specific lymphoid fates? Furthermore, what are the genome-wide changes in mRNA splicing patterns for key developmental regulators (e.g., IKZF1, BCL11A, GATA3) following the loss of these specific hnRNPs? 2. **Hypothesis: Bioenergetic State as a Driver of Epigenetic Priming.** The highly specific expression of mitochondrial respiratory chain components, including [COX4I1](/details-gene/1327) and multiple ATP synthase subunits, suggests that high oxidative phosphorylation (OXPHOS) is a critical functional characteristic, not merely a housekeeping activity. We hypothesize that this elevated metabolic state generates key metabolites (e.g., acetyl-CoA, alpha-ketoglutarate) that serve as essential cofactors for epigenetic modifying enzymes, thereby shaping the chromatin landscape to prime the cell for lymphoid lineage commitment. * **Surprising Findings:** The high specificity of genes involved in a ubiquitous process like cellular respiration is unexpected. This implies that the *quantitative level* of OXPHOS in [lymphoid lineage restricted progenitor cells](/details-cell/CL0000838) is significantly different from other hematopoietic cell types and may serve a unique, instructive role in this specific developmental window. * **Testable Questions:** How does pharmacological inhibition of the electron transport chain or ATP synthase impact the differentiation capacity of lymphoid progenitors in vitro? Does such metabolic perturbation alter the landscape of key histone modifications, such as H3K27ac and H3K4me3, at the promoters and enhancers of critical lymphoid development genes?